12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Foundation Medicine, Eisai deal

Foundation will conduct genomic profiling in an international clinical trial of an undisclosed cancer candidate from Eisai. Foundation will prospectively identify...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >